REZLIDHIA
Active substance: olutasidenib
CAPSULE · OLUTASIDENIB 150 mg/1
United StatesActive
Marketing holder: Rigel Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- OLUTASIDENIB · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-96a0-7eb8-bc0b-da4808cf5393;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71332-005
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 71332-005 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71332-005 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71332-005 · Verified 2026-10-09 · open in source